416
Participants
Start Date
April 22, 2021
Primary Completion Date
September 23, 2024
Study Completion Date
December 11, 2024
Experimental: Tezepelumab
Tezepelumab subcutaneous injection
Placebo
Placebo subcutaneous injection
Research Site, Budapest
Research Site, Budapest
Research Site, Budapest
Research Site, København NV
Research Site, Hvidovre
Research Site, Hillerød
Research Site, Nyíregyháza
Research Site, Køge
Research Site, Odense
Research Site, Vejle
Research Site, Pécs
Research Site, Székesfehérvár
Research Site, Aarhus N
Research Site, Siófok
Research Site, Aalborg
Research Site, New York
Research Site, Berlin
Research Site, Jerez de la Frontera
Research Site, Berlin
Research Site, Santiago de Compostela
Research Site, White Marsh
Research Site, Baltimore
Research Site, Norfolk
Research Site, Lübeck
Research Site, Winston-Salem
Research Site, Madrid
Research Site, North Charleston
Research Site, Boca Raton
Research Site, Marburg
Research Site, Birmingham
Research Site, Seville
Research Site, Barakaldo
Research Site, Milwaukee
Research Site, Chicago
Research Site, Wiesbaden
Research Site, Columbia
Research Site, Heidelberg
Research Site, Tübingen
Research Site, Oklahoma City
Research Site, Dallas
Research Site, Denver
Research Site, Colorado Springs
Research Site, Newport Beach
Research Site, Bakersfield
Research Site, Walnut Creek
Research Site, Roseville
Research Site, Spokane
Research Site, Shanghai
Research Site, Shanghai
Research Site, Nanjing
Research Site, Suzhou
Research Site, Taizhou
Research Site, Bengbu
Research Site, Qingdao
Research Site, Tianjin
Research Site, Tianjin
Research Site, Hangzhou
Research Site, Hangzhou
Research Site, Wenzhou
Research Site, Nanchang
Research Site, Hengyang
Research Site, Wuhan
Research Site, Guangzhou
Research Site, Zunyi
Research Site, Chengdu
Research Site, Xi'an
Research Site, Lanzhou
Research Site, Yinchuan
Research Site, Boston
Research Site, Vancouver
Research Site, Hamilton
Research Site, London
Research Site, Montreal
Research Site, Montreal
Research Site, Montreal
Research Site, Québec
Research Site, Québec
Research Site, Québec
Research Site, Trois-Rivières
Research Site, Dresden
Research Site, Bunkyō City
Research Site, Chuo-shi
Research Site, Habikino-shi
Research Site, Ichikawa-shi
Research Site, Itabashi-ku
Research Site, Kashiwa-shi
Research Site, Kisarazu-shi
Research Site, Miyazaki
Research Site, Nagaoka-shi
Research Site, Nerima-ku
Research Site, Niigata
Research Site, Osaka
Research Site, Saitama-shi
Research Site, Sapporo
Research Site, Sendai
Research Site, Suwa-shi
Research Site, Toyonaka Shi
Research Site, Yokohama
Research Site, Yokohama
Research Site, Bialystok
Research Site, Bydgoszcz
Research Site, Krakow
Research Site, Nadarzyn
Research Site, Wroclaw
Research Site, Wroclaw
Research Site, Zawadzkie
Research Site, Łodź
Research Site, Barcelona
Research Site, Dundee
Research Site, London
Research Site, Manchester
Research Site, Stockport
Lead Sponsor
Collaborators (1)
Amgen
INDUSTRY
AstraZeneca
INDUSTRY